To comply with regular shelf-life testing updates imposed by the FDA for MidaSpot® COVID-19 Antibody Combo Detection Kit to be maintained as an Emergency Use Authorization (EUA) product, the following lots have been extended until the new dates as shown below:
Kit Lot Number | Test Card Lot Number | New Expiration Date |
15933 | 15932 | 2022.01.17 |
16203 | 16201 | 2022.01.30 |
16401 | 16399 | 2022.08.15 |
The FDA letter can be viewed/downloaded here.
For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com
Nirmidas Biotech, Inc.
319 N. Bernardo Ave
Mountain View, CA, 94043, USA
